AMRN Stock — Price, Charts & Analysis

Amarin Corporation plc (AMRN) has no trailing P/E shown and a forward P/E of 14.35x. This places AMRN in a lower earnings multiple territory based on the valuation data currently available on Worldtickers.

AMRN trades with 14.35x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether AMRN looks overvalued or undervalued.

AMRN's P/E of 14.35x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

AMRN's trailing EPS is -$1.17 and forward EPS is $0.98.

EPS, or earnings per share, shows how much profit Amarin Corporation plc generated for each share. AMRN's trailing EPS is -$1.17, and investors usually prefer EPS that is positive and growing over time.

Amarin Corporation plc has a market cap of $294.83M, making AMRN a small-cap stock based on the current market value shown on Worldtickers.

AMRN's latest stock price on Worldtickers is $14.06. The latest move is -$0.32 or -2.23%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

AMRN's quote includes a latest price of $14.06. The market open is $14.22. Previous close is $14.38. The intraday range is $14.05 to $14.36.

AMRN is down in the latest quote, with a move of -$0.32 or -2.23%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

AMRN generated $186.23M in trailing revenue. Revenue growth is -42.00%, which helps show whether demand is expanding or slowing.

AMRN's revenue growth is -42.00%, which is a negative demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

No, AMRN does not show positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is -$27.12M.

Gross margin is 41.96%. Margins show how efficiently Amarin Corporation plc turns revenue into profit.

Amarin Corporation plc carries $7.18M and holds $314.65M in cash.

AMRN holds $314.65M on its balance sheet.

AMRN's book value per share is $21.12.

Institutions hold 22.49% of AMRN shares. Insiders hold 37.17% of shares. Ownership mix helps investors understand how much of Amarin Corporation plc is held by professional investors and company insiders.

AMRN has 20.97M shares outstanding. Float shares are 19.03M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for AMRN, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for AMRN is $0.98. Revenue growth is -42.00%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

AMRN's trailing EPS is -$1.17. Forward EPS is $0.98. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

AMRN is in the Healthcare sector. Its earnings multiple is 14.35x. Its latest displayed growth metric is -42.00%. Compare these figures with sector peers before deciding whether Amarin Corporation plc is stronger or weaker than average.

AMRN trades at $14.06. The stock trades at 14.35x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Amarin Corporation plc's fundamentals.

AMRN risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.77, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

AMRN should be compared with companies in Drug Manufacturers - General. Its earnings multiple is 14.35x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Amarin Corporation plc (AMRN) operates in Healthcare, specifically Drug Manufacturers - General. Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy

AMRN trades on NasdaqCM. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

AMRN stock is priced in USD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Amarin Corporation plc's official website listed on Worldtickers is investor.amarincorp.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Amarin Corporation plc employs about 80 people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Amarin Corporation plc is headquartered in Dublin, Ireland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

AMRN is in the Healthcare sector and the Drug Manufacturers - General industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

AMRN has traded between $12.96 and $20.90 over the past 52 weeks. At $14.06, it is 32.73% below the high and 8.49% above the low. The 52-week range helps gauge long-term price momentum.

AMRN is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is $14.75 and its 200-day moving average is $14.85.

AMRN's RSI is 45.09. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

AMRN's latest RSI reading is 45.09, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for AMRN is near $13.47. Key resistance is near $14.60. Breaks above resistance or below support can change the short-term technical setup.

AMRN's nearest reported support level is $13.47. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

AMRN's nearest reported resistance level is $14.60. A breakout above resistance can improve momentum, especially when volume confirms the move.

AMRN trades about 74.42K shares daily on average. The latest displayed volume is 31.5K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

AMRN's MACD is 0.04, which is a positive momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

AMRN is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 45.09 (neutral). MACD is bullish. Nearest support is around $13.47. Resistance is around $14.60. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is $14.13 (-0.46% from price). MA50 is $14.75 (-4.71% from price). MA200 is $14.85 (-5.33% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. AMRN's MA20 is $14.13. MA50 is $14.75. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

AMRN's pivot is near $14.34. Support is near $13.47. Resistance is near $14.60. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for AMRN is near $13.56. The next upper resistance zone is near $14.56. These levels help define risk and possible follow-through zones after a breakout or breakdown.

AMRN's Bollinger range is roughly $13.72 to $14.53. Band width is near 5.75%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

AMRN's ATR-based typical daily range is about 3.07%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 31.5K shares. Average volume is about 74.42K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

AMRN's all-time high shown on Worldtickers is $28,500.00. Its all-time low is $7.00. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

AMRN has a beta of 0.77, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.